PMID- 29544609 OWN - NLM STAT- MEDLINE DCOM- 20190729 LR - 20191210 IS - 1558-3597 (Electronic) IS - 0735-1097 (Linking) VI - 71 IP - 11 DP - 2018 Mar 20 TI - Radiation Exposure of Operators Performing Transesophageal Echocardiography During Percutaneous Structural Cardiac Interventions. PG - 1246-1254 LID - S0735-1097(18)30201-8 [pii] LID - 10.1016/j.jacc.2018.01.024 [doi] AB - BACKGROUND: Transesophageal echocardiography operators (TEEOP) provide critical imaging support for percutaneous structural cardiac intervention procedures. They stand close to the patient and the associated scattered radiation. OBJECTIVES: This study sought to investigate TEEOP radiation dose during percutaneous structural cardiac intervention. METHODS: Key personnel (TEEOP, anesthetist, primary operator [OP1], and secondary operator) wore instantly downloadable personal dosimeters during procedures requiring TEE support. TEEOP effective dose (E) and E per unit Kerma area product (E/KAP) were calculated. E/KAP was compared with C-arm projections. Additional shielding for TEEOP was implemented, and doses were measured for a further 50 procedures. Multivariate linear regression was performed to investigate independent predictors of radiation dose reduction. RESULTS: In the initial 98 procedures, median TEEOP E was 2.62 muSv (interquartile range [IQR]: 0.95 to 4.76 muSv), similar to OP1 E: 1.91 muSv (IQR: 0.48 to 3.81 muSv) (p = 0.101), but significantly higher than secondary operator E: 0.48 muSv (IQR: 0.00 to 1.91 muSv) (p < 0.001) and anesthetist E: 0.48 muSv (IQR: 0.00 to 1.43 muSv) (p < 0.001). Procedures using predominantly right anterior oblique (RAO) and steep RAO projections were associated with high TEEOP E/KAP (p = 0.041). In a further 50 procedures, with additional TEEOP shielding, TEEOP E was reduced by 82% (2.62 muSv [IQR: 0.95 to 4.76] to 0.48 muSv [IQR: 0.00 to 1.43 muSv] [p < 0.001]). Multivariate regression demonstrated shielding, procedure type, and KAP as independent predictors of TEEOP dose. CONCLUSION: TEE operators are exposed to a radiation dose that is at least as high as that of OP1 during percutaneous cardiac intervention. Doses were higher with procedures using predominantly RAO projections. Radiation doses can be significantly reduced with the use of an additional ceiling-suspended lead shield. CI - Crown Copyright (c) 2018. Published by Elsevier Inc. All rights reserved. FAU - Crowhurst, James A AU - Crowhurst JA AD - Cardiology Department, The Prince Charles Hospital, Chermside, Queensland, Australia; University of Queensland, St. Lucia, Queensland, Australia. Electronic address: Jimcrowhurst@hotmail.com. FAU - Scalia, Gregory M AU - Scalia GM AD - Cardiology Department, The Prince Charles Hospital, Chermside, Queensland, Australia; University of Queensland, St. Lucia, Queensland, Australia. FAU - Whitby, Mark AU - Whitby M AD - Biomedical Technical Services, The Prince Charles Hospital, Chermside, Queensland, Australia. FAU - Murdoch, Dale AU - Murdoch D AD - Cardiology Department, The Prince Charles Hospital, Chermside, Queensland, Australia; University of Queensland, St. Lucia, Queensland, Australia. FAU - Robinson, Brendan J AU - Robinson BJ AD - Cardiology Department, The Prince Charles Hospital, Chermside, Queensland, Australia. FAU - Turner, Arianwen AU - Turner A AD - Medical Imaging Department, The Prince Charles Hospital, Chermside, Queensland, Australia. FAU - Johnston, Liesie AU - Johnston L AD - Medical Imaging Department, The Prince Charles Hospital, Chermside, Queensland, Australia. FAU - Margale, Swaroop AU - Margale S AD - Department of Anaesthesia, The Prince Charles Hospital, Chermside, Queensland, Australia. FAU - Natani, Sarvesh AU - Natani S AD - Department of Anaesthesia, The Prince Charles Hospital, Chermside, Queensland, Australia. FAU - Clarke, Andrew AU - Clarke A AD - Department of Cardio-thoracic Surgery, The Prince Charles Hospital, Chermside, Queensland, Australia. FAU - Burstow, Darryl J AU - Burstow DJ AD - Cardiology Department, The Prince Charles Hospital, Chermside, Queensland, Australia; University of Queensland, St. Lucia, Queensland, Australia. FAU - Raffel, Owen C AU - Raffel OC AD - Cardiology Department, The Prince Charles Hospital, Chermside, Queensland, Australia; University of Queensland, St. Lucia, Queensland, Australia. FAU - Walters, Darren L AU - Walters DL AD - Cardiology Department, The Prince Charles Hospital, Chermside, Queensland, Australia; University of Queensland, St. Lucia, Queensland, Australia. LA - eng PT - Journal Article PT - Observational Study PL - United States TA - J Am Coll Cardiol JT - Journal of the American College of Cardiology JID - 8301365 CIN - J Am Coll Cardiol. 2018 Mar 20;71(11):1255-1258. PMID: 29544610 MH - Australia MH - *Echocardiography, Transesophageal/adverse effects/methods MH - Female MH - Humans MH - Male MH - *Occupational Exposure/analysis/prevention & control MH - Outcome Assessment, Health Care MH - Percutaneous Coronary Intervention/*methods MH - Radiation Dosage MH - *Radiation Exposure/analysis/prevention & control MH - Radiation Protection/*methods OTO - NOTNLM OT - echocardiography OT - exposure OT - intervention OT - radiation OT - reduction EDAT- 2018/03/17 06:00 MHDA- 2019/07/30 06:00 CRDT- 2018/03/17 06:00 PHST- 2017/08/22 00:00 [received] PHST- 2018/01/08 00:00 [revised] PHST- 2018/01/11 00:00 [accepted] PHST- 2018/03/17 06:00 [entrez] PHST- 2018/03/17 06:00 [pubmed] PHST- 2019/07/30 06:00 [medline] AID - S0735-1097(18)30201-8 [pii] AID - 10.1016/j.jacc.2018.01.024 [doi] PST - ppublish SO - J Am Coll Cardiol. 2018 Mar 20;71(11):1246-1254. doi: 10.1016/j.jacc.2018.01.024.